Hepatitis C RNA Qual HEPCRNAQL

Synonyms

Allscripts (AEHR) Order Name

Hepatitis C RNA, Qualitative

Sunrise Clinical Manager (SCM) Order Name

Hepatitis C RNA, Qualitative

Clinical Info

This test is a qualitative molecular for the detection of HCV in blood.

Specimen Type

Blood

Container

Plasma Prepared Tube

Collection Instructions

Specimen must arrive same day as drawn.
Container:  Lavender, PPT or Gold top tubes
Specimen: 1.5 mL plasma or serum (0.6 mL min)
Transport Temperature:  Frozen
Collection
Draw blood in a PPT™ VACUTAINER(S)®. Spin down, separate, immediately freeze 5 mL of plasma (1 ml Min) in original VACUTAINER(S)®. Send specimen frozen.
 
or
 
Draw blood in 2 Lavender-top(EDTA) tubes. Refrigerate during transport.  This specimen should be collected solely for HCV PCR testing and not used for other laboratory tests.
 
or
 
One Gold top tube Refrigerated during transport-Spun. This specimen should be collected solely for HCV PCR testing and not used for other laboratory tests. Frozen
Minimum Volume does not allow for repeat testing.
Stability:
3 days Room Temperature 
14  days Refrigerated
6 Months Frozen
 

Transport Instructions

Frozen

Specimen Stability

3 days Room Temperature 
14  days Refrigerated
6 Months Frozen
 

Methodology

Nucleic acid amplification (NAA)
 

Days Performed

Monday- Friday 3 - 5 Days

Performing Laboratory

LabCorp

CPT

87521
 
LOINC Code: 11259-9

PDM

6350035

Result Interpretation

Not detected
 
The limit of detection: 12 IU/mL.
 
Not Detected:  HCV RNA is not detected; possibly indicates resolved past infection or a false                              reactive antibody result. 
 
Detected:         HCV RNA is detected; indicates hepatitis C virus infection.
 
CDC guidelines and New York State require confirmation of reactive hepatitis C antibody screening tests. Results should be viewed in the context of clinical history and other lab tests. An indeterminate result indicates that HCV RNA result is inconclusive; please consider retesting with a new sample.   The performance characteristics of this assay have been determined by North-LIJ Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test, however, FDA clearance or approval is not currently required for clinical use.

Forms